JAK and STAT signaling molecules in immunoregulation and immune-mediated disease
- PMID: 22520847
- PMCID: PMC3499974
- DOI: 10.1016/j.immuni.2012.03.014
JAK and STAT signaling molecules in immunoregulation and immune-mediated disease
Abstract
The discovery of the Janus kinase (JAK)-signal transducer and activator of transcripton (STAT) signaling pathway, a landmark in cell biology, provided a simple mechanism for gene regulation that dramatically advanced our understanding of the action of hormones, interferons, colony-stimulating factors, and interleukins. As we learn more about the complexities of immune responses, new insights into the functions of this pathway continue to be revealed, aided by technology that permits genome-wide views. As we celebrate the 20(th) anniversary of the discovery of this paradigm in cell signaling, it is particularly edifying to see how this knowledge has rapidly been translated to human immune disease. Not only have genome-wide association studies demonstrated that this pathway is highly relevant to human autoimmunity, but targeting JAKs is now a reality in immune-mediated disease.
Copyright © 2012 Elsevier Inc. All rights reserved.
Conflict of interest statement
JO’S and National Institutes of Health (NIH) hold patents related to targeting JAKs as targets for immunomodulatory agents and have a Collaborative Research Agreement and Development Award with Pfizer.
Figures
Similar articles
-
The JAK-STAT pathway at 30: Much learned, much more to do.Cell. 2022 Oct 13;185(21):3857-3876. doi: 10.1016/j.cell.2022.09.023. Cell. 2022. PMID: 36240739 Free PMC article. Review.
-
Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential.Biochem Pharmacol. 2021 Nov;193:114760. doi: 10.1016/j.bcp.2021.114760. Epub 2021 Sep 4. Biochem Pharmacol. 2021. PMID: 34492272 Review.
-
Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases.Clin Immunol. 2018 Apr;189:4-13. doi: 10.1016/j.clim.2016.09.014. Epub 2016 Oct 3. Clin Immunol. 2018. PMID: 27713030 Free PMC article. Review.
-
The JAK/STAT signaling pathway: from bench to clinic.Signal Transduct Target Ther. 2021 Nov 26;6(1):402. doi: 10.1038/s41392-021-00791-1. Signal Transduct Target Ther. 2021. PMID: 34824210 Free PMC article. Review.
-
Targeting cytokine signaling in autoimmunity: back to the future and beyond.Curr Opin Immunol. 2016 Dec;43:89-97. doi: 10.1016/j.coi.2016.10.001. Epub 2016 Nov 4. Curr Opin Immunol. 2016. PMID: 27821272 Review.
Cited by
-
Kinase inhibit region of SOCS3 attenuates IL6-induced proliferation and astrocytic differentiation of neural stem cells via cross talk between signaling pathways.CNS Neurosci Ther. 2023 Jan;29(1):168-180. doi: 10.1111/cns.13992. Epub 2022 Oct 10. CNS Neurosci Ther. 2023. PMID: 36217678 Free PMC article.
-
Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury.Am J Physiol Lung Cell Mol Physiol. 2016 Nov 1;311(5):L868-L880. doi: 10.1152/ajplung.00281.2016. Epub 2016 Sep 16. Am J Physiol Lung Cell Mol Physiol. 2016. PMID: 27638904 Free PMC article.
-
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.EMBO Mol Med. 2022 Dec 7;14(12):e15200. doi: 10.15252/emmm.202115200. Epub 2022 Nov 7. EMBO Mol Med. 2022. PMID: 36341492 Free PMC article.
-
Hitting the right spot: Mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3).Mol Oncol. 2015 Jun;9(6):1194-206. doi: 10.1016/j.molonc.2015.02.012. Epub 2015 Mar 5. Mol Oncol. 2015. PMID: 25777967 Free PMC article.
-
Tyrosine kinase inhibitors for the treatment of rheumatoid arthritis.Curr Top Med Chem. 2013;13(6):760-73. doi: 10.2174/15680266113139990094. Curr Top Med Chem. 2013. PMID: 23574525 Free PMC article. Review.
References
-
- Alloza I, Otaegui D, de Lapuente AL, Antiguedad A, Varade J, Nunez C, Arroyo R, Urcelay E, Fernandez O, Leyva L, et al. ANKRD55 and DHCR7 are novel multiple sclerosis risk loci. Genes and Immunity 2011 - PubMed
-
- Batten M, Ramamoorthi N, Kljavin NM, Ma CS, Cox JH, Dengler HS, Danilenko DM, Caplazi P, Wong M, Fulcher DA, et al. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. The Journal of experimental medicine. 2010;207:2895–2906. - PMC - PubMed
-
- Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. Journal of Immunology. 2007;178:280–290. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials